1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is patented as a reagent to synthesize quinoxaline derivatives or heterocyclylamine derivatives as PI3 kinase inhibitors.
參考文獻
Li, Y., et al.: PCT Int. Appl.?(2013),?WO?2013033569?A1?20130307; Chaudhari, A., et al.: PCT Int. Appl. (2008), WO?2008141065?A1?20081120.